Characteristics of Breast Cancers with Concurrent Focal Thyroid Incidentalomas Using 18F-Fluorodeoxyglucose Positron Emission Tomography

키워드

참고문헌 (30)

1. Kang KW, "Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects", J Clin Endocrinol Metab, 88, pp.4100~4104 (2003)
2. positron emission tomography in relatively young healthy subjects : results of 3-year follow-up, "Endocr J", 2010, 395~401
3. Prichard RS, "Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation", Ir Med J, 104, pp.177~179 (2011)
4. Kim KJ, "Incidence and characteristics of thyroid nodules in patients with breast cancer", J Korean Breast Cancer Soc, 4, pp.115~119 (2001)
5. Bomanji JB, "Clinical role of positron emission tomography in oncology", Lancet Oncol, 2, pp.157~164 (2001)
6. Chen YK, "Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects", Anticancer Res, 25, pp.1421~1426 (2005)
7. "Cancer Registry and statistics between 2003-2005" (2008)[URL]
8. Kim BH, "Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation", Ann Nucl Med, 24, pp.721~728 (2010)
9. Wolff AC, "American Society of Clinical Oncology", College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, 2007, pp.25, 118~145
10. Cheang MC, "Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer", J Natl Cancer Inst, 101, pp.736~750 (2009)
11. Cibas ES, "Indications for thyroid FNA and pre-FNA requirements : a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference", Diagn Cytopathol, 36, pp.390~399 (2008)
12. Cibas ES, "NCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology", Am J Clin Pathol, 132, pp.658~665 (2009)
13. Kim TY, "18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram(PET)for evaluation in cancer patients : high prevalence of malignancy in thyroid PET incidentaloma", Laryngoscope, 115, pp.1074~1078 (2005)
14. Yasuda S, "Chronic thyroiditis : diffuse uptake of FDG at PET", Radiology, 207, pp.775~778 (1998)
15. Boerner AR, "Glucose metabolism of the thyroid in Graves’ disease measured by F-18-fluoro-deoxyglucose positron emission tomography", Thyroid, 8, pp.765~772 (1998)
16. Giani C, "Relationship between breast cancer and thyroid disease : relevance of autoimmune thyroid disorders in breast malignancy", J Clin Endocrinol Metab, 81, pp.990~994 (1996)
17. Smyth PP, "Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma", J Clin Endocrinol Metab, 83, pp.2711~2716 (1998)
18. Jiskra J, "Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival", Oncol Rep, 18, pp.1603~1611 (2007)
19. Farahati J, "Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer", Clin Chem Lab Med, 50, pp.709~714 (2012)
20. Giustarini E, "Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery", Eur J Endocrinol, 154, pp.645~649 (2006)
21. Franceschi S, "Breast cancer risk and history of selected medical conditions linked with female hormones", Eur J Cancer, 26, pp.781~785 (1990)
22. Tateishi U, "Chronic thyroiditis in patients with advanced breast carcinoma : metabolic and morphologic changes on PET-CT", Eur J Nucl Med Mol Imaging, 36, pp.894~902 (2009)
23. Cristofanilli M, "Thyroid hormone and breast carcinoma : primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma", Cancer, 103, pp.1122~1128 (2005)
24. Cohen MS, "Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography", Surgery, 130, pp.941~946 (2001)
25. Choi JY, "Focal thyroid lesions incidentally identified by integrated 18F-FDG PET", CT : clinical significance and improved characterization, 2006, pp.47, 609~615
26. Santin AP, "Role of estrogen in thyroid function and growth regulation", J Thyroid Res, 2011, pp.875125~ (2011)
27. Kamat A, "Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways", Arch Otolaryngol Head Neck Surg, 137, pp.1146~1153 (2011)
28. Di Vito M, "Overexpression of estrogen receptor- in human papillary thyroid carcinomas studied by laser-capture microdissection and molecular biology", Cancer Sci, 102, pp.1921~1927 (2011)
29. Cheng S, "A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior", Clin Cancer Res, 17, pp.2385~2394 (2011)
30. Huang Y, "Differential expression patterns and clinical significance of estrogen receptor- and  in papillary thyroid carcinoma", BMC Cancer, 14, pp.383~ (2014)

관련 논문AI추천